We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Moves Ahead With PDUFA VII Commitments on Real-World Evidence
FDA Moves Ahead With PDUFA VII Commitments on Real-World Evidence
The FDA has selected the initial applications for participation in its Advancing Real-World Evidence (RWE) program, which allows pharmaceutical sponsors four meetings with the agency to discuss proposals to use RWE in drug development.